PDS Biotechnology (PDSB) Net Equity Issued and Repurchased (2015 - 2026)
PDS Biotechnology's Net Equity Issued and Repurchased came in at $204,908 for Q2 2026.
Powered by 
Analysis
PDS Biotechnology (PDSB) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, PDS Biotechnology reported Net Equity Issued and Repurchased of $2.92 million, down 59.7% year-over-year; for FY2025, it was $9.71 million.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -20.1% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $774,091 in FY2024 (-95.2%), $16.13 million in FY2023 (+63.6%), $9.86 million in FY2022 (-79.7%) and $48.54 million in FY2021 (+63.1%).
- The Q2 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | 204,908.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 204,908.00 |
| Dec 31, 2025 | 2.71 Mn |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 144,500.00 |
| Sep 30, 2024 | 98,500.00 |
| Mar 31, 2024 | 531,091.00 |
| Dec 31, 2023 | 10.48 Mn |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 9.83 Mn |
| Jun 30, 2022 | 22,429.00 |
| Mar 31, 2022 | 7,488.00 |
| Jun 30, 2021 | 48.54 Mn |
| Sep 30, 2020 | 17.79 Mn |
| Mar 31, 2020 | 11.97 Mn |
| Mar 31, 2019 | 750,000.00 |
| Dec 31, 2018 | 50,630.00 |
| Sep 30, 2018 | 173,368.00 |
| Jun 30, 2018 | 3.00 |
API Access
PDS Biotechnology Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();